{
  "docId": "019de072-122c-721c-8b62-3522a74ffc66",
  "docSlug": "bcca0cb7dade19d9f637477238714c68",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 33,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The chart is a box plot showing arginine levels over time, with reference lines for normal and target ranges.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/21",
  "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66",
  "deckJsonHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66.json",
  "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.44,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "callout",
      "text": "Pegzilarginase is a novel recombinant human enzyme engineered to lower arginine levels",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e99ee93a-34ec-42b4-a150-c57bef3a3996",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.44,
        "x": 0.04,
        "y": 0.4
      },
      "kind": "chart",
      "text": "Plasma Arginine in Response to Pegzilarginase in Phase 1/2 & OLE Studies",
      "attrs": null,
      "subkind": "box",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c97e65b6-4019-4ca4-a9d0-2539b84fadc6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.54,
        "x": 0.04,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "Pegzilarginase is an investigational drug and has not been approved by the U.S. Food and Drug Administration",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "230af6a9-5a90-4940-b577-bc2df8c12c76",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.45,
        "x": 0.51,
        "y": 0.21
      },
      "kind": "list",
      "text": "First Clinical Program Ever Conducted in ARG1-D; Phase 1/2 and Open-Label Extension Trials; PEACE Phase 3 Clinical Trial",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c30b2b9b-93f2-4964-94ad-9ae16329146f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.43,
        "x": 0.038,
        "y": 0.05
      },
      "kind": "title",
      "text": "Pegzilarginase Program Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f15ac07-1cda-49d8-bd05-83140f070c1b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 21,
      "from": 21,
      "beatId": "58843c7c-2fb4-4f23-b948-1e8f60ffbb00",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Pegzilarginase Program Overview",
      "beatSlug": null,
      "evidence": "The deck provides an overview of the Pegzilarginase program",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 26,
      "from": 21,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "9cc0cacb-1c5c-40f5-a519-d219894ab0a2",
      "evidence": "The deck provides clinical data supporting the effectiveness of Pegzilarginase",
      "position": 1,
      "objective": "Show the potential of Pegzilarginase to improve patient outcomes",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.7,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}